Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDS

Berrey, M. Michelle; Schacker, Timothy; Collier, Ann C.; Shea, Theresa; Brodie, Scott J.; Mayers, Douglas; Coombs, Robert; Krieger, John; Chun, Tae-Wook; Fauci, Anthony; Self, Steven G.; Corey, Lawrence
May 2001
Journal of Infectious Diseases;5/15/2001, Vol. 183 Issue 10, p1466
Academic Journal
Discusses the clinical benefits of antiretroviral therapy in primary HIV type 1 infection. Virologic response to antiretroviral therapy; Effect of combination antiretroviral therapy on CD4... T cells; Adverse events and adherence to medications.


Related Articles

  • AIDS: A Review of Targets and Approaches for Treatment. Gupta, S. D.; Ramteke, Suman; Gupta, A.; Moorthy, N. S. H. N. // Indian Journal of Pharmaceutical Sciences;2007, Vol. 69 Issue 2, p173 

    Untreated HIV infection is characterized by a gradual deterioration of immune function. Most notably, crucial immune cells known as CD4 positive T lymphocytes are disabled and killed during the typical course of infection. These T lymphocyte cells play central role in the immune response. The...

  • Stabilized Human TRIM5α Protects Human T Cells From HIV-1 Infection. Richardson, Max W; Guo, Lili; Xin, Frances; Yang, Xiaolu; Riley, James L // Molecular Therapy;Jun2014, Vol. 22 Issue 6, p1084 

    Rhesus (rh) but not human (hu) TRIM5α potently restricts human immunodeficiency virus (HIV)-1 infection. It is not clear why huTRIM5α fails to effectively block HIV infection, but it is thought to have a lower affinity for the viral core. Using primary human CD4 T cells, we investigated...

  • TO THE EDITOR. Freeman, Michael L.; Mudd, Joseph C.; Shive, Carey L.; Younes, Souheil-Antoine; Panigrahi, Soumya; Sieg, Scott F.; Lee, Sulggi A.; Hunt, Peter W.; Calabrese, Leonard H.; Gianella, Sara; Rodriguez, Benigno; Lederman, Michael M. // Clinical Infectious Diseases;6/1/2016, Vol. 62 Issue 11, p1468 

    A response from the authors of the article "CD8 T-cell expansion and inflammation linked to CMV coinfection in ART-treated HIV infection" in the 2016 issue is presented.

  • Proliferative Responses to Human Immunodeficiency Virus Type 1 (HIV-1) Antigens in HIV-1-Infected Patients with Immune Reconstitution. Blankson, Joel N.; Gallant, Joel E.; Siliciano, Robert F. // Journal of Infectious Diseases;2/15/2001, Vol. 183 Issue 4, p657 

    Features a study on human immunodeficiency virus type 1 (HIV-1)-specific CD4 T cell proliferative responses in HIV-1-infected patients who began highly active antiretroviral therapy with low CD4 cell count nadirs and experienced immune reconstitution. Background of the CD4 T cells; Patients and...

  • Immune-Based Therapy for HIV Infection: Are Acute and Chronic HIV Infection Different Diseases? Hunt, Peter W.; Deeks, Steven G. // Journal of Infectious Diseases;12/15/2006, Vol. 194 Issue 12, p1632 

    The article expresses the author's view on the immune-based therapy for HIV infection on acute and chronic HIV infection. T cell activation is an important element in the pathogenesis of HIV, although it may cause the loss of some cells and that T cell activation and apoptosis may be the most...

  • Are We Done Monkeying Around With TRIM5α? Campbell, Edward // Molecular Therapy;Jun2014, Vol. 22 Issue 6, p1072 

    The author discusses aspects of the stabilization of human tripartite motif-containing protein 5 (TRIM5) alpha protein which restrict the human immunodeficiency virus (HIV-1) infection in human T cells. He states that TRIM5 alpha has the ability to inhibit the infection between the member of...

  • Science Translational Medicine: Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article offers information on the report published in Science Translational Medicine regarding the treatment of patients infected with Human Immunodeficiency Virus (HIV) with genetically modified T cell therapy.

  • Discordant Increases in CD4[sup+] T Cells in Human Immunodeficiency Virus-Infected Patients Experiencing Virologic Treatment Failure: Role of Changes in Thymic Output and T Cell Death. Lecossier, Denise; Bouchonnet, Francine; Clavel, Francois; Hance, Allan J.; Schneider, Pascal // Journal of Infectious Diseases;4/1/2001, Vol. 183 Issue 7, p1009 

    Presents information on a study which explored the mechanisms responsible for discordant treatment responses in patients infected with HIV. Patients and methods; Clinical characteristics of patients with virologic treatment failure; Evaluation of T cell receptor excision circles

  • Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV-1 Disease. Kalayjian, Robert C.; Spritzler, John; Pu, Minya; Landay, Alan; Pollard, Richard B.; Stocker, Vicki; Harthi, Lena-Al; Gross, Barry H.; Francis, Isaac R.; Fiscus, Susan A.; Tebas, Pablo; Bosch, Ronald J.; Valcour, Victor; Lederman, Michael M. // Journal of Infectious Diseases;11/1/2005, Vol. 192 Issue 9, p1577 

    Background. We have attempted to identify factors associated with T cell reconstitution in response to highly active antiretroviral therapy. Methods. In a prospective, multicenter cohort study, we compared clinical, immune, and viral responses to an initial antiretroviral regimen in older...

  • The maturation of antibody technology for the HIV epidemic. Winnall, Wendy R; Beasley, Matthew D; Center, Rob J; Parsons, Matthew S; Kiefel, Ben R; Kent, Stephen J // Immunology & Cell Biology;Aug2014, Vol. 92 Issue 7, p570 

    Antibodies are one of our most useful biological tools. Indeed, improvements in antibody-based technologies have ushered in a new era of antibody-based therapeutics, research and diagnostic tools. Although improved technologies have led to the development of therapeutic antibodies for treatment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics